Infertility

Updated: 2026-09-20

Overview

Infertility affects approximately 15% of couples globally, with causes spanning ovulatory disorders (e.g., PCOS), tubal factors, endometriosis, male factor (low sperm count/motility), and unexplained origins. The WHO classifies it as a disease requiring multidisciplinary management through reproductive endocrinologists, embryologists, and andrologists. Diagnostic standards follow ASRM guidelines, involving semen analysis, hormonal profiling, hysterosalpingography, and ovarian reserve testing. Recent advancements include genetic testing for karyotype abnormalities and sperm DNA fragmentation analysis, revolutionizing personalized treatment approaches.

Key Features

Modern infertility management emphasizes evidence-based protocols: ovulation induction (clomiphene/letrozole), intrauterine insemination (IUI), and ART (IVF/ICSI). Success rates vary by age, with <35-year-olds achieving 40-50% live birth rates per IVF cycle versus 10-15% for those >42. Emerging technologies like time-lapse embryo imaging and preimplantation genetic testing (PGT-A) optimize outcomes. Male infertility treatments now include micro-TESE sperm retrieval and oxidative stress reduction therapies. The field increasingly addresses lifestyle modifiable factors like BMI management and smoking cessation.

Application Areas

Fertility clinics require specialized equipment: laminar flow hoods for embryo handling, cryopreservation tanks (-196°C liquid nitrogen storage), and ISO-certified cleanrooms. Andrology labs need computer-assisted semen analysis (CASA) systems and sperm cryopreservation kits. Hospital procurement focuses on FDA-cleared ART consumables (culture media, vitrification devices) and hormone assays. Pharmaceutical partnerships supply recombinant FSH/LH and gonadotropin-releasing analogs. Emerging markets show demand for cost-effective ICSI solutions and minimal stimulation protocols.

Precautions

Medical equipment must comply with FDA 21 CFR Part 820 (QSR) and EU IVDR standards for ART devices. Strict chain-of-custody protocols apply for gamete/embryo handling per ASRM guidelines. Laboratories require CAP/CLIA certification for genetic testing. Ethical considerations include informed consent for embryo disposition and donor gamete use. Legal frameworks vary by jurisdiction - some prohibit gender selection or surrogacy. Cybersecurity is critical for electronic medical records containing sensitive genetic data.

B2B Procurement Guide

When sourcing infertility solutions, prioritize suppliers with ISO 13485 certification for medical devices and validated ART consumables. Key evaluation criteria include clinical validation studies, batch-to-batch consistency, and technical support availability. For pharmaceuticals, verify cold chain logistics for gonadotropins. Equipment purchases should include service contracts for incubator calibration and microscope maintenance. Group purchasing organizations (GPOs) can negotiate bulk pricing for high-volume IVF centers. Always audit supplier success rates and complication data.